How Middle Eastern Markets Are Transforming Drug Reviews And Driving Competitiveness
The UAE, Jordan, Egypt and Saudi Arabia have all recently announced or implemented new verification/abridged regulatory pathways to improve access to medicines and free up resources.
You may also be interested in...
The rare and orphan drug company Amryt speaks to the Pink Sheet about how to do business in the Middle East and why seeking marketing authorization could be a better long-term strategy than catering for named patient requests.
Kuwait is the latest market in the Middle East to introduce a new regulatory procedure for speeding up market entry of innovative new drugs. However, industry experts would like to see it go further.
Medicines regulators from the Pacific Alliance have taken a step towards greater regional regulatory harmonization in a bid to make registration of medicines faster.